By API User
LTR Pharma Limited (ASX:LTP) (“LTR Pharma”, “the Company”), a Company focused on improving men’s health through clinical development and commercialisation of an innovative nasal spray treatment for erectile dysfunction (“ED”), SPONTAN®, is pleased to provide its Appendix 4C for the quarter ended 30 September 2024. Highlights: SPONTAN® prescribed to first patients under the Therapeutic Goods … Continued
By API User
GENEVA–BUSINESS WIRE– On World Stroke Day, October 29, the World Stroke Organization (WSO) announces the launch of a global coalition aimed at accelerating policy action on stroke—now the second leading cause of death and the third leading cause of disability worldwide. Over the past three decades, the global burden of stroke has doubled. Stroke’s impact … Continued
By API User
Cardiovascular disease (CVD) remains a leading cause of death and disability in Australia. While this burden can seem overwhelming, the nation’s cardiovascular leaders believe that with improved coordination and pathways for prioritised translation our talented researchers can make substantial impacts on prevention, early disease detection and treatment. Addressing this pressing challenge, the Cardiovascular Health … Continued
By API User
Some Australian mothers regard navigating their personal health care in between pregnancies as confusing, inconsistent, and hard to access, new research by a Monash University-led team has found. The focus of consultations between pregnancies is mostly on babies and children, while the health needs of mothers can be neglected with potentially negative consequences for women … Continued
By API User
The Australian Government is helping more Australians to quit smoking, including those living in regional and remote areas. Tobacco smoking remains the leading cause of preventable disease and death in Australia and the number of people who smoke tobacco daily is higher in regional areas than major cities. People in remote and very remote areas … Continued
By API User
The acquisition expands Organon’s dermatology capabilities with a nonbiologic, non-steroidal topical treatment in the U.S. JERSEY CITY, N.J.–BUSINESS WIRE– Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, today announced the successful completion of its acquisition of Dermavant Sciences Ltd. from Roivant (NASDAQ: ROIV). Dermavant … Continued
By API User
SAN MATEO, Calif.–BUSINESS WIRE– BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, is saddened to share the news that Donald Glazer recently passed away. Don was a Board member and the chair of the nominating and corporate governance committee. Co-founder, Chairman and CEO John V. Oyler issued the following statement: “We … Continued
By API User
DUBAI, United Arab Emirates, Oct. 28, 2024 (GLOBE NEWSWIRE) — Dubai Billionaire and founder of PFOAA Anosh Ahmed and its foundation announces today that it is donating ten millions of pounds of essential food to Lebanon. Anosh Ahmed “In times of hardship and recovery, no one should face hunger alone. As Lebanon heals from the … Continued
By API User
Collaboration will expand access to high sensitivity NULISA immunoassays for clinical biomarker analysis. GENT, Belgium & FREMONT, Calif.–BUSINESS WIRE– ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a leader in ultra-sensitive immunoassay technologies, today announced a partnership in the development of customized biomarker assay … Continued
By API User
Preparations are underway for the spookiest night of the year. But why do we love being scared out of our minds? NeuRA Senior Research Fellow, Dr Steve Kassem, is available to answer this question and more. Afterall, brains aren’t scary, they’re spectacular, so let’s breakdown the ick and explore the incredible! Dr Kassem has … Continued
